Ironwood Pharmaceuticals (IRWD) Insider Trading & Ownership $0.74 +0.05 (+7.67%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.74 0.00 (-0.37%) As of 07/16/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ironwood Pharmaceuticals (NASDAQ:IRWD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$447.66K Get IRWD Insider Trade Alerts Want to know when executives and insiders are buying or selling Ironwood Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IRWD Insider Buying and Selling by Quarter Ironwood Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/10/2025Michael ShetzlineCMOSell41,269$1.76$72,633.44 2/10/2025Ronald SilverInsiderSell12,048$1.76$21,204.48 2/10/2025Thomas A MccourtCEOSell139,064$1.76$244,752.64 11/18/2024Andrew DavisSVPSell5,360$4.08$21,868.80 11/18/2024Sravan Kumar EmanyCFOSell11,001$4.08$44,884.08 8/12/2024Minardo JohnInsiderSell9,910$4.27$42,315.70 (Data available from 1/1/2013 forward) IRWD Insider Trading Activity - Frequently Asked Questions Who is on Ironwood Pharmaceuticals' Insider Roster? The list of insiders at Ironwood Pharmaceuticals includes Andrew Davis, Catherine Moukheibir, Jason Rickard, Jon R Duane, Julie Mchugh, Mark G Currie, Michael Shetzline, Minardo John, Ronald Silver, Sravan Kumar Emany, and Thomas A Mccourt. Learn more on insiders at IRWD. What percentage of Ironwood Pharmaceuticals stock is owned by insiders? 12.70% of Ironwood Pharmaceuticals stock is owned by insiders. Learn more on IRWD's insider holdings. Which Ironwood Pharmaceuticals insiders have been buying company stock? The following insiders have purchased IRWD shares in the last 24 months: Jon R Duane ($60,204.00), and Sravan Kumar Emany ($400,334.96). How much insider buying is happening at Ironwood Pharmaceuticals? Insiders have purchased a total of 53,676 IRWD shares in the last 24 months for a total of $460,538.96 bought. Which Ironwood Pharmaceuticals insiders have been selling company stock? The following insiders have sold IRWD shares in the last 24 months: Andrew Davis ($171,921.84), Catherine Moukheibir ($282,549.36), Julie Mchugh ($143,198.14), Michael Shetzline ($661,171.76), Minardo John ($764,386.90), Ronald Silver ($21,204.48), Sravan Kumar Emany ($44,884.08), and Thomas A Mccourt ($2,944,732.00). How much insider selling is happening at Ironwood Pharmaceuticals? Insiders have sold a total of 558,852 Ironwood Pharmaceuticals shares in the last 24 months for a total of $5,034,048.56 sold. Ironwood Pharmaceuticals Key ExecutivesMr. Thomas A. McCourt (Age 67)CEO & Director Compensation: $1.61M1 recent tradesMr. Sravan Kumar Emany (Age 46)Senior VP, Principal Financial Officer & CFO Compensation: $913.88kMr. John Minardo (Age 48)Senior VP, Chief Legal Officer & Secretary Compensation: $814.41kDr. Michael Shetzline M.D. (Age 65)Ph.D., Chief Medical Officer, Senior VP and Head of Research & Drug Development Compensation: $860.45kMr. Andrew Davis (Age 37)Senior VP & Chief Business Officer Compensation: $824.36kMr. Ronald Silver (Age 41)Corporate Controller & Principal Accounting Officer 1 recent tradesMr. Marcel MoulaisonVice President of Technical OperationsGreg MartiniVice President of Strategic Finance & Investor RelationsMs. Beth CalitriHead of Corporate Communications & Media RelationsMr. Mike NanfitoVice President of Sales & Sales Excellence More Insider Trading Tools from MarketBeat Related Companies AbbVie Insider Trades Emergent Biosolutions Insider Trades Rigel Pharmaceuticals Insider Trades Lexicon Pharmaceuticals Insider Trades XOMA Royalty Insider Trades Vanda Pharmaceuticals Insider Trades Verastem Insider Trades Codexis Insider Trades Agenus Insider Trades Sangamo Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:IRWD) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
